Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 167

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

PROTEINS OF THE BCL‐2 FAMILY IN APOPTOSIS SIGNALLING: FROM MECHANISTIC INSIGHTS TO THERAPEUTIC OPPORTUNITIES

Chan, Shing‐Leng, Yu, Victor C · 2004 · Clinical and Experimental Pharmacology and Physiology

Abstract

SUMMARY: 1. Proteins of the Bcl‐2 family are central regulators of apoptosis and are thought to act primarily on the mitochondria. 2. Members of the Bcl‐2 family possess either anti‐apoptotic or pro‐apoptotic function. They are characterized by the presence of conserved sequence motifs, known as Bcl‐2 homology (BH) domains. Anti‐apoptotic members share all four BH domains, designated as BH1‐4; the multidomain pro‐apoptotic members contain BH1‐3 domains, whereas another subgroup of pro‐apoptotic members only have a BH3 domain. 3. The BH3‐only proteins act as sensors for distinct apoptosis pathways, whereas multidomain pro‐apoptotic Bax and Bak are executioners of death orders relayed by the BH3‐only proteins. 4. Anti‐apoptotic Bcl‐2 family members appear to function, at least in part, by interacting with and antagonizing pro‐apoptotic family members. The BH1‐3 domains of BclXL form an elongated hydrophobic groove, which is the docking site for the BH3 domains of pro‐apoptotic binding partners. 5. The deregulation of the various Bcl‐2 proteins has been implicated in many pathological conditions. 6. Knowledge derived from the understanding of the function and regulation of the Bcl‐2 family of proteins has allowed us to contemplate new therapeutic strategies for diseases where apoptosis signalling mechanisms can potentially be manipulated. 7. The anti‐apoptotic Bcl‐2 members have been targeted successfully using an antisense approach, BH3‐peptides and small molecular weight chemicals that are inhibitors of their anti‐apoptotic function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1440-1681.2004.03975.x

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 167

Metadata

Authors
Chan, S., & Yu, V. C.
Venue
Clinical and Experimental Pharmacology and Physiology
Publisher
Wiley
Published
2004-02-19
Volume
31
Issue
3
Pages
119-128
ISSN
  • 0305-1870 (ISSN-L)
  • 1440-1681
OpenAlex
W2003388311
Cited by
167
References
13
FWCI
4.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PROTEINS OF THE BCL‐2 FAMILY IN APOPTOSIS SIGNALLING: FROM MECHANISTIC INSIGHTS TO THERAPEUTIC OPPORTUNITIES. https://app.cochat.ai/papers/10.1111/j.1440-1681.2004.03975.x
The paper
Chan, S., & Yu, V. C. (2004). PROTEINS OF THE BCL‐2 FAMILY IN APOPTOSIS SIGNALLING: FROM MECHANISTIC INSIGHTS TO THERAPEUTIC OPPORTUNITIES. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/j.1440-1681.2004.03975.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.